Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients
Public ClinicalTrials.gov record NCT05769582. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients, a Randomized Phase II/III Study, Double-blind and Placebo-controlled
Study identification
- NCT ID
- NCT05769582
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- Memo Therapeutics AG
- Industry
- Enrollment
- 95 participants
Conditions and interventions
Conditions
Interventions
- Anti-BK polyomavirus (AntiBKV) Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 9, 2023
- Primary completion
- Mar 18, 2025
- Completion
- Jul 14, 2025
- Last update posted
- Sep 28, 2025
2023 – 2025
United States locations
- U.S. sites
- 23
- U.S. states
- 18
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Mayo Clinic | Phoenix | Arizona | 85054 | — |
| University of California, Los Angeles | Los Angeles | California | 90024 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| University of California Davis | Sacramento | California | 95817 | — |
| Hartford Hospital | Hartford | Connecticut | 06105 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06520 | — |
| MedStar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | — |
| Mayo Clinic Transplant Center | Jacksonville | Florida | 32224 | — |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | — |
| University of Maryland | Baltimore | Maryland | 21201 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Harvard Medical School | Boston | Massachusetts | 02215 | — |
| University of Michigan Health System | Ann Arbor | Michigan | 48109 | — |
| Washington University School of Medicine in St. Louis | St Louis | Missouri | 63110 | — |
| Saint Barnabas Medical Center | Livingston | New Jersey | 07039 | — |
| New York Presbyterian Hospital - Weill Cornell Medical Center | New York | New York | 10065 | — |
| Metrolina Nephrology Associates (MNA), PA | Charlotte | North Carolina | 28207 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| University of Pennsylvania Hospital of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| UT Southwestern | Dallas | Texas | 75390 | — |
| University of Washington Medical Center | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05769582, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 28, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05769582 live on ClinicalTrials.gov.